Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer
2021 · Nature Communications · 108 citations
https://doi.org/10.1038/s41467-021-23053-8
X
Xiangyan Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
702
Citations
13
h-index
17
i10-index
Xiangyan Jiang is an academic researcher from Lanzhou University Second Hospital. The author has contributed to research in topics: Epigenetics and DNA Methylation & Microtubule and mitosis dynamics & Gastric Cancer Management and Outcomes. The author has an h-index of 13, co-authored 40 publications.
ORCID: 0000-0002-2685-2899Papers by this author
worksA novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
2020 · Oncogene · 103 citations
https://doi.org/10.1038/s41388-020-01572-w
The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis
2020 · BMC Gastroenterology · 26 citations
https://doi.org/10.1186/s12876-020-01255-6
PANoptosis in Bacterial Infections: A Double-Edged Sword Balancing Host Immunity and Pathogenesis
2025 · Pathogens · 18 citations
https://doi.org/10.3390/pathogens14010043
Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study
2024 · Med · 14 citations
https://doi.org/10.1016/j.medj.2024.10.008
Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
2021 · BMC Cancer · 10 citations
https://doi.org/10.1186/s12885-021-08769-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat